Clinical Review of Juvenile Huntington’s Disease
Journal of Huntington's Disease · 2024
DOI: 10.3233/jhd-231523 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Huntington's Disease, 2024. Verfasst von Mayke Oosterloo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Juvenile Huntington’s disease (JHD) is rare. In the first decade of life speech difficulties, rigidity, and dystonia are common clinical motor symptoms, whereas onset in the second decade motor symptoms may sometimes resemble adult-onset Huntington’s disease (AOHD). Cognitive decline is mostly detected by declining school performances. Behavioral symptoms in general do not differ from AOHD but may be confused with autism spectrum disorder or attention deficit hyperactivity disorder and lead to misdiagnosis and/or diagnostic delay. JHD specific features are epilepsy, ataxia, spasticity, pain, itching, and possibly liver steatosis. Disease progression of JHD is faster compared to AOHD and the disease duration is shorter, particularly in case of higher CAG repeat lengths. The diagnosis is based on clinical judgement in combination with a positive family history and/or DNA analysis after careful consideration. Repeat length in JHD is usually > 55 and caused by anticipation, usually via paternal transmission. There are no pharmacological and multidisciplinary guidelines for JHD treatment. Future perspectives for earlier diagnosis are better diagnostic markers such as qualitative MRI and neurofilament light in serum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
- School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
- Department of Neurodegenerative Disease, UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
- Department of Neurology, Huntington Centre NRW, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany.
- Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
- Department of Neurology, Division of Child Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Förderung
- NICHD NIH HHS
Zitieren
APA
Oosterloo, M., Touze, A., Byrne, L. M., Achenbach, J., Aksoy, H., Coleman, A., Lammert, D., Nance, M., Nopoulos, P., Reilmann, R., Saft, C., Santini, H., Squitieri, F., Tabrizi, S., Burgunder, J. M., Quarrell, O., & Pediatric Huntington Disease Working Group of the European Huntington Disease Network (2024). Clinical Review of Juvenile Huntington’s Disease. Journal of Huntington's Disease. https://doi.org/10.3233/jhd-231523
Vancouver
Oosterloo M, Touze A, Byrne LM, Achenbach J, Aksoy H, Coleman A, et al. Clinical Review of Juvenile Huntington’s Disease. Journal of Huntington's Disease. 2024. doi:10.3233/jhd-231523
BibTeX
@article{Oosterloo2024,
author = {Oosterloo, Mayke and Touze, Alexiane and Byrne, Lauren M and Achenbach, Jannis and Aksoy, Hande and Coleman, Annabelle and Lammert, Dawn and Nance, Martha and Nopoulos, Peggy and Reilmann, Ralf and Saft, Carsten and Santini, Helen and Squitieri, Ferdinando and Tabrizi, Sarah and Burgunder, Jean-Marc and Quarrell, Oliver and Pediatric Huntington Disease Working Group of the European Huntington Disease Network, Pediatric Huntington Disease Working Group of the European Huntington Disease Network},
title = {Clinical Review of Juvenile Huntington’s Disease},
journal = {Journal of Huntington's Disease},
year = {2024},
doi = {10.3233/jhd-231523}
}
EUVIMED